Global and United States Chemical CDMO Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and United States Chemical CDMO Market Report & Forecast 2024-2034
CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.
Market Analysis and InsightsGlobal and United States Chemical CDMO Market
This report focuses on global and United States Chemical CDMO market, also covers the segmentation data of other regions in regional level and county level.
The global Chemical CDMO revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Chemical CDMO revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Chemical CDMO include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. The global five biggest players hold a share of % in 2022.
Global Chemical CDMO Scope and Market Size
Chemical CDMO market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Chemical CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Chemical CDMO market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Pharmaceutical Company
Biotechnology Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Chemical CDMO definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Chemical CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Chemical CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemical CDMO revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Chemical CDMO Market
This report focuses on global and United States Chemical CDMO market, also covers the segmentation data of other regions in regional level and county level.
The global Chemical CDMO revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Chemical CDMO revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Chemical CDMO include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. The global five biggest players hold a share of % in 2022.
Global Chemical CDMO Scope and Market Size
Chemical CDMO market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Chemical CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Chemical CDMO market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Chemical CDMO definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Chemical CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Chemical CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemical CDMO revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices